Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.31% | 324.21 | 0.0% | $4670.09m | |
| BNTX | BioNTech SE | -1.06% | 247.68 | 0.0% | $730.32m | |
| NVAX | Novavax, Inc. | -4.59% | 161.95 | 79.4% | $715.24m | |
| AMGN | Amgen, Inc. | 0.51% | 207.84 | 1.4% | $575.65m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -7.57% | 6.47 | 0.7% | $452.28m | |
| GILD | Gilead Sciences, Inc. | -0.76% | 67.63 | 1.0% | $426.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.43% | 553.24 | 2.7% | $408.99m | |
| ILMN | Illumina, Inc. | 0.45% | 409.93 | 3.3% | $392.87m | |
| CCXI | ChemoCentryx, Inc. | -7.04% | 34.47 | 2.9% | $387.64m | |
| XLRN | Acceleron Pharma, Inc. | 0.50% | 172.94 | 5.3% | $345.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.07% | 181.77 | 1.9% | $259.59m | |
| BIIB | Biogen, Inc. | -1.43% | 281.19 | 1.7% | $243.39m | |
| OCGN | Ocugen, Inc. | -13.83% | 8.66 | 0.0% | $178.37m | |
| XENE | Xenon Pharmaceuticals, Inc. | 2.12% | 33.66 | 0.4% | $178.19m | |
| JSPR | Jasper Therapeutics, Inc. | 31.57% | 16.42 | 0.0% | $158.53m |
Company Profile
Mirati Therapeutics, Inc. operates as a clinical-stage oncology company, which engages in the development of novel therapeutics. The firm's products targets the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.